Home Featured Page 270

Featured

Latest

“I’m All About the Data”: Dr. Charles Nemeroff on Psychedelics, Ibogaine, and Scientific Rigour

After the Readout: How the Field Is Interpreting Compass’ Phase 3 Psilocybin Data

Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts

Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast

BREAKING: Second Positive Phase 3 for Compass’ Psilocybin, Though Modest Magnitude Raises Questions

Revive Therapeutics Files for FDA Orphan Drug Designation for Psilocybin in...

Bright Minds Biosciences Appoints Industry Experts for Key Roles and Expands...

Awakn Life Sciences Initiates New Chemical Entity Development Program with Evotec...

MINDCURE Announces Partnership with SOMA Breath Inc. to License its Breathwork...

PT241 – Nick Meyers and Tyler Chandler of “Dosed”: Iboga and...

MindMed Begins Trading on Nasdaq

Psyched Wellness Initiates the Next Pre-Clinical Trial Study on AME-1

PharmaTher Expands Patent Portfolio with Filing of U.S. Patent Application for...

MindMed Becomes Second Psychedelic Drug Development Company to List on the...

PsyBio and Miami University Broaden Partnership Agreement for the Continued Advancement...

EDITOR PICKS

“I’m All About the Data”: Dr. Charles Nemeroff on Psychedelics, Ibogaine,...

After the Readout: How the Field Is Interpreting Compass’ Phase 3...

Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

“I’m All About the Data”: Dr. Charles Nemeroff on Psychedelics, Ibogaine, and Scientific Rigour

After the Readout: How the Field Is Interpreting Compass’ Phase 3 Psilocybin Data

Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts

Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast

BREAKING: Second Positive Phase 3 for Compass’ Psilocybin, Though Modest Magnitude Raises Questions

Revive Therapeutics Files for FDA Orphan Drug Designation for Psilocybin in...

Bright Minds Biosciences Appoints Industry Experts for Key Roles and Expands...

Awakn Life Sciences Initiates New Chemical Entity Development Program with Evotec...

MINDCURE Announces Partnership with SOMA Breath Inc. to License its Breathwork...

PT241 – Nick Meyers and Tyler Chandler of “Dosed”: Iboga and...

MindMed Begins Trading on Nasdaq

Psyched Wellness Initiates the Next Pre-Clinical Trial Study on AME-1

PharmaTher Expands Patent Portfolio with Filing of U.S. Patent Application for...

MindMed Becomes Second Psychedelic Drug Development Company to List on the...

PsyBio and Miami University Broaden Partnership Agreement for the Continued Advancement...

EDITOR PICKS

“I’m All About the Data”: Dr. Charles Nemeroff on Psychedelics, Ibogaine,...

After the Readout: How the Field Is Interpreting Compass’ Phase 3...

Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY